JBIO

Conviction 31HealthcareScan · Mon, Jul 20, 2026

Bearish engulfing

JBIO$19.65-5.80%

ResistanceSupportVol 14

Vol MA14 1.05M

Apr 20May 6May 26Jun 11Jul 1Jul 20

Jade Biosciences, Inc.PHARMACEUTICAL PREPARATIONSwww.jadebiosciences.com ↗

Price19.65

Change-5.80%

Gap+2.30%

Rel volume0.81×

Avg volume1.2M

Avg $ vol25.66M

SMA 2021.50

SMA 5020.63

SMA 20016.03

Price vs 50-4.75%

Price vs 200+22.60%

MA stackmixed

50/200 cross—

Supertrendup · 17.97

RSI (14)44

MACD hist-0.21

MACD crossbear · 2d

Stoch %K / %D9 / 22

ADX (14)18

+DI / −DI15 / 19

RSI divergence—

MACD divergence—

ATR %+9.21%

ADR %8.64%

52w high26.85

52w low6.77

From 52w high-26.82%

Above 52w low+190.25%

New 52w highNo

SqueezeOn · 1d

Bollinger width15.70%

%B-0.05

Donchian pos35.46%

Donchian high23.49

Donchian low17.54

AVWAP (52w high)20.08

vs AVWAP high-2.15%

AVWAP (52w low)17.63

vs AVWAP low+11.48%

OBV trendUp

Chaikin MF (20)-0.00

Today vs 20d0.81×

Avg vol (14d)1.05M

Avg vol (20d)1.2M

Avg $ vol (20d)25.66M

Market cap969.92M

RS 3m (vs SPY)-10.59%

RS 6m (vs SPY)+34.62%

RS line new highNo

Trend template5/8

Technical rank73.3

1 week-7.75%

1 month+16.48%

3 months-14.00%

6 months+33.67%

1 year+106.62%

YTD+38.77%

P/E-7.61

P/B3.27

P/S—

P/FCF-10.22

EPS-3.19

Div yield—

ROE-42.98%

ROA-39.89%

Debt/Eq—

Current14.29

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-82.99%

Price target49.00

Target upside149.36%

Analyst ratingBuy

Institutional85.53%

Ent. value914.84M

Revenue—

Net income-40.37M

Gross profit—

Free cash flow-94.89M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out49.36M

Employees55

ListedTue, Apr 29, 2025

Free float41.37M

Float %83.9%

Short interest8.15M

Days to cover4.8d

Short volume65.9%

Squeeze score81 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.57 vs −$0.52

Last surprise-9.6% miss

Setup gradeD

Conviction31 / 100

Pattern quality—

Tech rank73.3 / 100

Group rank23 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBearish engulfing

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in JBIO

All disclosures →

No recent disclosed trades by Congress in JBIO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in JBIO

No recent insider (Form 4) filings in JBIO. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in JBIO · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.